Task: Answer the multiple-choice question.
Question: Which drug exhibits a 2.721% human ether-à-go-go related gene (hERG) inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any other words.
Options:
(a) Cc1ccc(C(=O)Nc2cc(C)nn2CCC#N)cc1
(b) Cc1cc2cc(CN(Cc3cccs3)C(=S)NCC3CCCO3)c(=O)[nH]c2cc1C
(c) Cc1ccccc1C(=O)NCCc1nnc(SCC(=O)Nc2nc(-c3ccccc3)cs2)n1C
(d) COc1ccc(Nc2cc(C(=O)NCCCN3CCN(C)CC3)c3ccccc3n2)cc1
(e) CN(C)c1ccc(/C=N/NC(=O)COc2ccccc2)cc1
Answer: d. COc1ccc(Nc2cc(C(=O)NCCCN3CCN(C)CC3)c3ccccc3n2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1ccc(Nc2cc(C(=O)NCCCN3CCN(C)CC3)c3ccccc3n2)cc1
COc1ccc(Nc2cc(C(=O)NCCCN3CCN(C)CC3)c3ccccc3n2)cc1
2-(4-methoxyanilino)-N-[3-(4-methylpiperazin-1-yl)propyl]quinoline-4-carboxamide